Atwater Malick LLC’s Quest Diagnostics Inc Position
Does Atwater Malick LLC own Quest Diagnostics Inc (DGX)? Yes — 30.3K shares worth $6M (+1.60% of its 13F portfolio) as of Q1 2026, down from 35.3K shares the prior filed quarter.
Position Value
$6M
Q1 2026
Shares
30.3K
% of Portfolio
+1.60%
Quarters Held
29
currently held
Position History DGX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 30.3K | $6M | +1.60% |
| Q4 2025 | 35.3K | $6M | +1.69% |
| Q3 2025 | 42.9K | $8M | +2.38% |
| Q2 2025 | 56.7K | $10M | +3.22% |
| Q1 2025 | 56.6K | $10M | +3.24% |
| Q4 2024 | 55.1K | $8M | +2.79% |
| Q3 2024 | 55.6K | $9M | +2.78% |
| Q2 2024 | 54.9K | $8M | +2.59% |
| Q1 2024 | 54.7K | $7M | +2.57% |
| Q4 2023 | 54.0K | $7M | +2.92% |
| Q3 2023 | 52.7K | $6M | +2.83% |
| Q2 2023 | 52.1K | $7M | +3.13% |
| Q1 2023 | 50.4K | $7M | +3.34% |
| Q4 2022 | 49.6K | $8M | +3.83% |
| Q3 2022 | 48.8K | $6M | +3.35% |
| Q2 2022 | 47.5K | $6M | +3.33% |
| Q1 2022 | 46.4K | $6M | +3.07% |
| Q4 2021 | 44.1K | $8M | +3.54% |
| Q3 2021 | 43.4K | $6M | +3.33% |
| Q2 2021 | 42.4K | $6M | +3.09% |
| Q1 2021 | 39.5K | $5M | +3.11% |
| Q4 2020 | 41.5K | $5M | +3.11% |
| Q3 2020 | 41.1K | $5M | +3.30% |
| Q2 2020 | 40.4K | $5M | +3.62% |
| Q1 2020 | 38.6K | $3M | +2.97% |
| Q4 2019 | 36.0K | $4M | +3.06% |
| Q3 2019 | 34.6K | $4M | +3.11% |
| Q2 2019 | 33.1K | $3M | +3.09% |
| Q1 2019 | 32.2K | $3M | +2.83% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atwater Malick LLC’s full portfolio or all institutional holders of DGX.